You are a fit if
- You have run trials, or want to lead them
- You have an established practice
- You want sponsors to see your site first
For lead investigators
Gold standard design. More sites. More studies. More medicine for US patients, faster.
CMBH is a platform that helps you leverage your investigator experience to bring in more sites and reach more patients, so you can do more studies. Our CRO partner adds gold standard methodology and design, so each study gives sponsors the evidence they need to bring a product to market. You lead the science.
Takes two minutes. No commitment.
1Gold standard designMethodology and study design support from our CRO partner
2More sitesQualified sites in new regions, working alongside you
3More studiesNew studies come to you before the wider network
4More medicine, fasterMore patients reached, so better options arrive sooner
Who we work with
Head PIs on the best studies
We are set up to work with head PIs and lead investigators, so the best studies get done with the best people.
25+years of study design experience at our CRO partner
30+sponsors worked with
10in-house statisticians
100person full service CRO team
Who this is for
Is this you?
You get
- New studies before the wider network
- More sites and more patients behind your studies
- Study design and technical support, with you leading the science
Why CMBH
Built around the lead PI
Our team lobbies Washington for more studies, so you do not have to. You focus on your patients and your science.
You lead the science
Scientific direction stays with you. Your role is set out in writing, and each site keeps its own qualified investigator.
Room to grow
Bring your research to more qualified sites and patient communities, confirmed study by study.
Study design support
Our CRO partner brings protocol, statistics, regulatory and data expertise, so studies are designed to give sponsors the evidence they need and you can focus on the science.
One friendly front door
Work with sponsors on coordinated multi-site studies through a single point of contact.
How it works
A new study, built with you and yours to see first
Enrollment is where good studies stall. So we start with what patients and providers actually want, then bring in sites that help you reach them.
1
We hear what is needed
A sponsor needs sites and investigators in your region.
2
We shape it with you
You, our CRO partner and the sponsor fine tune the study around what patients and providers want.
3
New sites join behind you
Qualified sites in new regions bring more patients into the study.
4
You see it first, and lead it
Lead investigators get the first look and keep scientific leadership.
For example: a sponsor needs six sites for a migraine study. You hear first, help shape it, and nearby sites join behind you.
The lead investigator role
What leading with CMBH looks like
A lead investigator provides scientific leadership across participating sites. It is a defined role, set out in a written agreement, and it never replaces the qualified principal investigator at each site.
Scientific leadership
Shape the research question, protocol input and interpretation with sponsors and partners.
Mentor site investigators
Guide advancing investigators and community practices as they build research experience.
Represent the program
Serve as the scientific voice of the program with sponsors and collaborators.
Getting started
Three steps
Introduce yourself
Share your specialty, experience and areas of research interest.
Talk through fit
A conversation about your goals, current programs and where a network could help.
Take your role
Join as a lead investigator under written agreements, with your role and fair market value compensation defined up front.
Questions
Quick answers
Do I give up control?
No. You lead the science. Your role is set out in a written agreement, and each site keeps its own qualified investigator.
What does it cost?
Joining the list is free. Any paid work is for work performed, at fair market value, under written agreements.
Do I need trial experience?
Experience helps. We also work with advancing investigators and practices that are building their research experience.
Beyond the lead role
Three levels of the CMBH investigator network
Lead investigators sit at Level 1. Levels 2 and 3 describe the investigators and practices they mentor and work with.
Level 1
Distinguished Investigators
Established research leaders with relevant trial experience, publications, and scientific credibility.
- May lead appropriate multi-site programs
- Mentor other investigators
- Expand reach through CMBH sites
Level 2
Advancing Investigators
Qualified clinicians or researchers building their trial portfolio, scientific contributions, and leadership credentials through mentorship and collaboration.
- Mentorship and collaboration
- Defined roles on studies
- Growing scientific leadership
Level 3
Clinical Research Partners
Independent practices interested in patient access to research and a pathway toward research participation. Some may begin as informational or referring practices, and others may qualify as active research sites.
- Qualification and training
- Staffing and oversight guidance
- A documented path upward
Levels 1 to 3 are CMBH professional-development categories. They are not FDA or IRB investigator classifications. A lead investigator does not automatically replace a qualified local PI at each site, and each activated site keeps its own investigator and assigned responsibilities.
What we offer
Legitimate mentorship and collaboration
- Mentorship and training
- Scientific collaboration
- Conference opportunities
- Authorship based on actual contribution
- Fair market value compensation for work performed, under written agreements
How progression works
Based on evidence, not seniority
Moving from Level 3 to Level 2 to Level 1 is based on documented competence, GCP conduct, research contributions, and operational performance, not age, media exposure, or promised publication.
We do not promise publications, media recognition, patients for a physician's ordinary practice, or advancement as a guaranteed benefit. Nothing is paid for patient referrals.